Discounted Cash Flow Rating

Buy

Return on Equity Rating

Sell

Debt to Equity Rating

Buy

Price to Earnings Rating

Strong Buy

Analyst Rating

Buy

Simple Moving Average

Neutral

Exponential Moving Average

Neutral

Relative Strength Index

Buy

Standard Deviation

Neutral

Williams %R

Strong Buy

Average Directional Index

Strong Sell

Insider Trading

Strong Buy

Wall Street Data Solutions Rating

Buy

A

Aurinia Pharmaceuticals Inc (AUPH)

Pharmaceutical Preparations

https://www.auriniapharma.com

Aurinia Pharmaceuticals Inc is a biopharmaceutical company. It provides products for patients suffering from serious diseases with a high unmet medical need. The firm is developing LUPKYNIS (voclosporin), an investigational drug, for the treatment of lupus nephritis (LN), focal segmental glomerulosclerosis (FSGS), and Dry Eye Syndrome (DES). Geographically, it derives maximum revenue from the United States.

#140, 14315 - 118 AVENUE
EDMONTON, A0

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

10/21/2009

Market Cap

864,380,595

Shares Outstanding

143,610,000

Weighted SO

143,608,164

Total Employees

N/A

Upcoming Earnings

08/01/2024

Similar Tickers

VKTX --.--%

AXSM --.--%

MDGL --.--%

IMGN --.--%

MCRB --.--%

EXEL --.--%

TGTX --.--%

BTAI --.--%

SRPT --.--%

Beta

1.4490

Last Div

0.0000

Range

4.71-10.24

Chg

0.4550

Avg Vol

1286275

Mkt Cap

864380595

Exch

NASDAQ

Country

CA

Phone

12507084272

DCF Diff

2.7726

DCF

6.5974

Div Yield

0.0000

P/S

4.1736

EV Multiple

-38.4082

P/FV

2.3762

Div Yield %

0.0000

P/E

-17.2081

PEG

-0.5945

Payout

0.0000

Current Ratio

5.3270

Quick Ratio

4.8218

Cash Ratio

0.4344

DSO

44.9797

DIO

491.9807

Op Cycle

536.9605

DPO

106.5559

CCC

430.4045

Gross Margin

0.8608

Op Margin

-0.2332

Pretax Margin

-0.2322

Net Margin

-0.2431

Eff Tax Rate

-0.0468

ROA

-0.0962

ROE

-0.1348

ROCE

-0.1081

NI/EBT

1.0468

EBT/EBIT

0.9960

EBIT/Rev

-0.2332

Debt Ratio

0.1642

D/E

0.2358

LT Debt/Cap

0.1631

Total Debt/Cap

0.1908

Int Coverage

-17.2769

CF/Debt

-0.0139

Equity Multi

1.4358

Rec Turnover

8.1148

Pay Turnover

3.4254

Inv Turnover

0.7419

FA Turnover

1.9145

Asset Turnover

0.3956

OCF/Share

-0.0084

FCF/Share

-0.0086

Cash/Share

2.3057

OCF/Sales

-0.0058

FCF/OCF

1.0335

CF Coverage

-0.0139

ST Coverage

-0.0802

CapEx Coverage

-29.8826

Div&CapEx Cov

-29.8826

P/BV

2.3762

P/B

2.3762

P/S

4.1736

P/E

-17.2081

P/FCF

-698.8581

P/OCF

-723.9421

P/CF

-723.9421

PEG

-0.5945

P/S

4.1736

EV Multiple

-38.4082

P/FV

2.3762

DPS

0.0000

Latest Headlines (EST)

No Headlines Found

Revenue Product Segmentation